An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Treatment Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Several experts stated the popularity for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or prison.
Service Response and Content Removal
Based on TikTok, the service has removed problematic material and banned associated keywords and query recommendations. The company said it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at residence.
After minutes of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.
Item Information and Costs
Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.
Her staff has already seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly significant health risks”.
